SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-22-046157
Filing Date
2022-04-15
Accepted
2022-04-14 20:08:28
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 tm2211216-1_s3.htm S-3 602956
2 EXHIBIT 5.1 tm2211216d2_ex5-1.htm EX-5.1 16189
3 EXHIBIT 23.1 tm2211216d2_ex23-1.htm EX-23.1 2205
4 EX-FILING FEES tm2211216d2_ex-filingfees.htm EX-FILING FEES 64799
5 GRAPHIC tm2211216d2_ex5-1img001.jpg GRAPHIC 3694
6 GRAPHIC lg_esperionreg-4c.jpg GRAPHIC 40119
  Complete submission text file 0001104659-22-046157.txt   747865
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-264303 | Film No.: 22828738
SIC: 2834 Pharmaceutical Preparations